Cargando…
Research and application of single-cell sequencing in tumor heterogeneity and drug resistance of circulating tumor cells
Malignant tumor is a largely harmful disease worldwide. The cure rate of malignant tumors increases with the continuous discovery of anti-tumor drugs and the optimisation of chemotherapy options. However, drug resistance of tumor cells remains a massive obstacle in the treatment of anti-tumor drugs....
Autores principales: | Dai, Zhe, Gu, Xu-yu, Xiang, Shou-yan, Gong, Dan-dan, Man, Chang-feng, Fan, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653877/ https://www.ncbi.nlm.nih.gov/pubmed/33292625 http://dx.doi.org/10.1186/s40364-020-00240-1 |
Ejemplares similares
-
Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
por: Sun, Yunfan, et al.
Publicado: (2021) -
Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance
por: Schmidt, Felix, et al.
Publicado: (2016) -
Whole Genome Sequencing of Single-Circulating Tumor Cell Ameliorates Unraveling Breast Cancer Heterogeneity
por: Li, Yongping, et al.
Publicado: (2022) -
Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer
por: Papadaki, Maria A., et al.
Publicado: (2022) -
Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
por: Tellez-Gabriel, Marta, et al.
Publicado: (2019)